FDA Clears Hologic's MammoSite(R) ML Radiation The MammoSite ML (multi-lumen) device offers more women the option of completing their radiation treatment in just five days.
Provides 'adequate control' of prostate cancer, averts side effects of conventional treatments
The patents concern positive pressure airway devices
Best Particle Therapy plans to bring smaller footprint system to market in two to three years
CIRS appoints new sales manager
Through R&D, the organizations will target cost-effective innovation
Read about AHRQ research on IMRT.
Checking in on radiation safety over two years after the international conference
UChicago Medicine appoints inaugural chair of the department of neurological surgery
